PROS1 and myeloid sarcoma: Additionally, CD11bhighCD4low monocytes also showed a significant increase in GAS6 and PROS1 in the HIMS cohort compared with the MS cohort (S1D and S1E Fig), which could contribute to minimizing the pathological inflammation.